Rimegepant

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 301 publications

A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

Journal: Cephalalgia : an international journal of headache

Published: June 11, 2026

CGRP reception potentiates anxiety in an influenza A derived immune engram.

CGRP reception potentiates anxiety in an influenza A derived immune engram.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2026

Migraine and depression: an important relationship

Migraine and depression: an important relationship

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: May 14, 2026

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Journal: Neurology

Published: May 06, 2026

Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.

Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.

Journal: Annals of internal medicine

Published: May 04, 2026

Does rimegepant prevent migraine attacks in people who have not found other treatments taken by mouth (orally) to work well? A plain language summary of clinical study findings.

Does rimegepant prevent migraine attacks in people who have not found other treatments taken by mouth (orally) to work well? A plain language summary of clinical study findings.

Journal: Pain management

Published: April 28, 2026

Can rimegepant stop symptoms of a migraine attack in people who have not found triptans to work well or are not recommended to use triptans? A plain language summary of a clinical study.

Can rimegepant stop symptoms of a migraine attack in people who have not found triptans to work well or are not recommended to use triptans? A plain language summary of a clinical study.

Journal: Pain management

Published: April 03, 2026

Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE study.

Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE study.

Journal: The journal of headache and pain

Published: March 23, 2026

Systematic review and meta-analysis on the efficacy and safety of rimegepant for migraine.

Systematic review and meta-analysis on the efficacy and safety of rimegepant for migraine.

Journal: Frontiers in neurology

Published: March 12, 2026

Halting neuron-fibroblast crosstalk disarms tumor and augments immunotherapy.

Halting neuron-fibroblast crosstalk disarms tumor and augments immunotherapy.

Journal: Trends in pharmacological sciences

Published: March 10, 2026

Rimegepant for the acute treatment of migraine: a systematic review and meta-analysis.

Rimegepant for the acute treatment of migraine: a systematic review and meta-analysis.

Journal: The journal of headache and pain

Published: February 10, 2026

A pilot, randomized, placebo-controlled trial of rimegepant on visceral sensation and symptoms in nonconstipation IBS pain.

A pilot, randomized, placebo-controlled trial of rimegepant on visceral sensation and symptoms in nonconstipation IBS pain.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: February 04, 2026

Showing 1-12 of 301

Last Updated: 06/30/2026